title: Utilization of evidence-based smoking cessation treatments by psychiatric inpatient smokers with depression.
abstract: OBJECTIVE
  Although smoking is a major health issue among depressed psychiatric inpatients and interest in quitting is high, successful quit rates remain low among this population. We sought to understand preferences that depressed inpatient smokers may have for cessation treatments.
  
  
  METHODS
  Eighty smokers (60% women, mean age 38.75 ± 11.20) with major depressive disorder and nicotine dependence receiving psychiatric inpatient services provided information on current depressive symptoms, smoking status and nicotine dependence, quit attempts, perceived barriers to quitting, and smoking consequences.
  
  
  RESULTS
  Almost half (46%) of participants endorsed a past-year quit attempt. Emotional barriers to quitting were uniquely associated with fewer past-year quit attempts, and depression severity was related to greater emotional barriers to quitting. Nicotine dependence severity was related to a variety of emotional, financial, weight concern, and self-efficacy barriers, but only weight gain concern was associated with decreased odds of making a past-year quit attempt. The number of lifetime quit attempts was positively associated with negative smoking consequences. With regard to interest in smoking cessation treatment, 86% and 92% of smokers reported a willingness to try behavioral counseling and nicotine replacement products, respectively, but fewer smokers reported a willingness to try medication, print or Web-based materials, or an unaided quit attempt.
  
  
  CONCLUSIONS
  Although half of our sample reported recent quit attempts, many people did not make an attempt using an evidence-based treatment. On the basis of consumer preferences identified herein, clinical recommendations for reinforcing the use of evidence-based smoking cessation treatments for depressed psychiatric inpatient smokers are provided.
authors.affiliation: From the Department of Family and Preventive Medicine (DRS), University of California, San Diego; Alpert Medical School of Brown University (LU, AMA, YS), Providence, RI; and Butler Hospital (LU, KF, JS, SM, AMA, YS), Providence, RI.
authors.forename: David R
authors.initials: DR
authors.lastname: Strong
authors.forename: Lisa
authors.initials: L
authors.lastname: Uebelacker
authors.forename: Kathryn
authors.initials: K
authors.lastname: Fokas
authors.forename: Jennifer
authors.initials: J
authors.lastname: Saritelli
authors.forename: Stephen
authors.initials: S
authors.lastname: Matsko
authors.forename: Ana M
authors.initials: AM
authors.lastname: Abrantes
authors.forename: Yael
authors.initials: Y
authors.lastname: Schonbrun
mesh_terms: D000328:Adult; D003865:Major Depressive Disorder / Q000150:complications / Q000523:psychology*; D004644:Emotions / Q000502:physiology; D019317:Evidence-Based Medicine / Q000379:methods*; D005260:Female; D006778:Hospitals, Psychiatric; D006801:Humans; D007297:Inpatients / Q000523:psychology* / Q000706:statistics & numerical data; D008297:Male; D020377:Self Efficacy; D012720:Severity of Illness Index; D016540:Smoking Cessation / Q000379:methods* / Q000523:psychology* / Q000706:statistics & numerical data; D014029:Tobacco Use Disorder / Q000150:complications / Q000523:psychology / Q000628:therapy*; D016896:Treatment Outcome; D015430:Weight Gain / Q000502:physiology